Pharma company Granules India today reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current fiscal. The company had posted a net profit of Rs 40.82 crore during the same period of the previous fiscal, Granules India said in a regulatory filing. Total income during the quarter under review stood at Rs 399.39 crore as against Rs 367.68 crore in the July-September quarter of the last fiscal. "As our emerging business is taking shape to drive future business growth, our core business continues to deliver sustainable revenues," Granules India CMD Krishna Prasad Chigurupati said. The company's stock closed 2.82 per cent down at Rs 130.80 apiece on BSE.
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)